One-Pot Multicomponent Synthesis of Diversely Substituted 2-Aminopyrroles. A Short General Synthesis of Rigidins A, B, C, and D
摘要:
Privileged medicinal scaffolds based on the structures of tetra- and pentasubstituted 2-aminopyrroles were prepared via one-pot multicomponent reactions of structurally diverse aldehydes and N-(aryl-, hetaryl-, alkylsulfonamido)acetophenones with activated methylene compounds. This methodology was used in a four-step synthesis of alkaloids rigidins A, B, C, and Din overall yields of 61%, 58%, 60%, and 53%, respectively. Of these, rigidins B, C, and D were synthesized for the first time.
NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND
申请人:Cellgentek Co., Ltd
公开号:EP4019495A1
公开(公告)日:2022-06-29
The present invention provides a novel compound that increases KAI1 promoter activity, a pharmaceutically acceptable salt thereof, and a composition for inhibiting cancer metastasis and invasion or treating colorectal cancer containing the same.
Novel three-component synthesis and antiproliferative properties of diversely functionalized pyrrolines
作者:Igor V. Magedov、Giovanni Luchetti、Nikolai M. Evdokimov、Madhuri Manpadi、Wim F.A. Steelant、Severine Van slambrouck、Paul Tongwa、Mikhail Yu. Antipin、Alexander Kornienko
DOI:10.1016/j.bmcl.2008.01.019
日期:2008.2
Diversely substituted 2-pyrrolines have been prepared by a novel multicomponent process involving a reaction of various N-(aryl- and alkylsulfonamido)-acetophenones with aldehydes and malononitrile. While the reaction is highly regioselective, it is not stereoselective, generating a mixture of cis and trans 2-pyrrolines. A number of analogs from both cis and trans 2-pyrroline libraries were found to have antiproliferative activity in human cancer cell lines. (c) 2008 Elsevier Ltd. All rights reserved.
[EN] NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND<br/>[FR] NOUVEAU COMPOSÉ AYANT UNE ACTIVITÉ INHIBITRICE DE MÉTASTASES CANCÉREUSES, SON PROCÉDÉ DE PRÉPARATION, ET COMPOSITION PHARMACEUTIQUE POUR L'INHIBITION DE MÉTASTASES CANCÉREUSES ET DE LEUR PROLIFÉRATION OU POUR LE TRAITEMENT DU CANCER COLORECTAL, COMPRENANT LEDIT COMPOSÉ<br/>[KO] 신규한 암전이 억제 활성을 갖는 화합물, 이의 제조방법 및 상기 화합물을 포함하는 암 전이 및 침윤 억제, 또는 대장암 치료용 약학적 조성물
申请人:CELLGENTEK CO LTD
公开号:WO2021034087A1
公开(公告)日:2021-02-25
본 발명은 신규한 KAI1 프로모터 활성을 증가시키는 화합물, 이의 약학적으로 허용가능한 염 및 이들을 포함하는 암 전이 및 침윤 억제용 또는 대장암 치료용 조성물을 제공한다.